3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Melanoma
2
Leukemia, Myeloid, Acute
2
Leukemia
2
Congenital Abnormalities
2
Carcinoma, Renal Cell
2
Uveal Melanoma
1
Small Cell Lung Carcinoma
1
Sarcoma
1
Rhabdomyosarcoma
1
Rhabdoid Tumor
1
Retinoblastoma
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Ovarian Neoplasms
1
Osteosarcoma
1
Optic Nerve Glioma
1
Oligodendroglioma
1
Neuroectodermal Tumors, Primitive, Peripheral
1
Neuroectodermal Tumors, Primitive
1
Neuroblastoma
1
Neoplasms, Neuroepithelial
1
Neoplasm Metastasis
1
Myelodysplastic Syndromes
1
Medulloblastoma
1
Lung Neoplasms
1
Liver Neoplasms
1
Leukemia, Myelomonocytic, Acute
1
Leukemia, Myeloid, Accelerated Phase
1
Leukemia, Monocytic, Acute
1
Leukemia, Megakaryoblastic, Acute
1
Leukemia, Erythroblastic, Acute
1
Interventions
Mycophenolic Acid
25
fludarabine phosphate
21
Whole-Body Irradiation
21
Cyclophosphamide
21
Cyclosporine
16
Tacrolimus
15
Peripheral Blood Stem Cell Transplantation
15
Busulfan
14
fludarabine
11
Cord Blood Stem Cell Transplantation
9
Methotrexate
8
Melphalan
8
Granulocyte Colony-Stimulating Factor
8
Cytarabine
8
Antilymphocyte Serum
8
Filgrastim
7
Thiotepa
6
Etoposide
6
sargramostim
4
merphos
4
Radiotherapy
4
Drug Therapy
4
Cyclosporins
4
Azacitidine
4
thymoglobulin
3
Vorinostat
3
Sirolimus
3
Lenalidomide
3
Idarubicin
3
tipifarnib
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Anemia, Refractory, with Excess of Blasts
×
Immunologic Techniques
×
Clear all
No trials found.